The Kitchen is empty.
Actual Experience 0.85p £1.8m (ACT.L)
The analytics-as-a-service company, announces that Iain McCready has been appointed as Chief Executive Officer (CEO) and will join the board of the Company as an Executive Director with effect from 1 June 2023. Mr McCready has extensive experience in the technology sector, with particular focus on driving revenue growth in early-stage innovative companies. Prior to joining, he was Chief Operating Officer of Quorum Cyber, and prior to that was CEO of Cortexica Vision Systems.
Brand Architekts Group 33.5p £9.4m (BAR.L)
A challenger British Beauty brand business, announces the appointment of Geoff Ellis to the Board as Chief Financial Officer with effect from 3 July on a part-time basis. Geoff has had a resounding career as an experienced Chief Financial Officer & Chief Operational Officer with senior executive roles at Walt Disney Incorporated. Charlotte Lee, and Group Financial Controller. Geoff is a chartered accountant and previously was CFO at Proteome PLC .
Chamberlin 3.1p £3.9m (CMH.L)
The specialist castings and engineering group, announces that it has conditionally raised approximately £330k at a placing price of 3p per share. The Placing Price represents a discount of 7.69% to the closing mid-market price of 3.25p per share. Trevor Brown, Executive Director, has also conditionally subscribed for 1,000,000 shares at the placing price raising an additional £30k. Net proceeds will provide working capital to take advantage of potential new opportunities which have recently arisen as a result of a competitor of Russell Ductile Castings Limited going into administration, support the continued delivery of the Group's growth strategy and strengthen the Group's balance sheet.
Echo Energy 0.033p £1.8m (ECHO.L)
The Latin American focused energy company, announces that, further to the Heads of Terms announced on 9 May 2023, the Company has now signed binding transaction documents for the Sale and Purchase Agreement signed with Selva Maria Oil S.A. and Interoil Exploration and Production ASA, for the proposed disposal of 65% out of the Company's current 70% working interest in Santa Cruz Sur for a cash consideration of up to £1.725m, consisting of: a cash consideration of £0.825m in an initial cash payment of £75k, contingent cash payments of £0.5m and payment in kind of £0.4m via issue of new shares in Interoil Exploration and Production ASA. The Company would retain a 5% non-operated working interest, with significantly lower exposure to ongoing costs and legacy in-country liabilities.
Hurricane Energy 7.6p £151.5m (HUR.L)
The UK based oil and gas company which has a 100% interest in and operates the Lancaster field, announces its full-year results for the period ended 31 December 2022. Revenues of $310.8m from six liftings of Lancaster crude (2021: $240.5m from seven liftings), Cash production costs increased to $37.4/bbl (2021: $28.2/bbl) and generated $175.9m of free cash flow, equivalent to $56.9/bbl (2021: $135.7m, $36.2bbl). Profit after tax increased to $108.7m (2021: $18.2m), an increase of 497% and holds cash of $121.4m (2021: $51.5m). Following an unsolicited offer for the Company, the Board decided to launch a Formal Sale Process (FSP), which, at the end of a thorough and exhaustive process, delivered an offer from Prax Exploration & Production PLC (Prax). The Court hearing to sanction the Scheme resulting from that offer is scheduled for 7 June 2023.
Pelatro 5.25p £2.4m (PTRO.L)
The precision marketing software specialist, announces results for the year ended 31 December 2022. Decrease in revenue by 26% to $5.4m (2021: $7.3m). Recurring revenue for the Company marginally down to $4.3m (2021: $4.8m) and adjusted EBITDA of $0.6m (2021: $2.8m) down 78%. The Company also faced impairment charges of $9.3m, primarily relating to intangible assets as a result of reduction in revenue. The Company added three new customers, bringing total to 26, increased presence in Africa and the Middle East and continued to retain customers at end of initial contracts. Post period, the Company has good visibility of new business pipeline of c.$23m, including some $5m of non telco business.
Polarean 22.5p £47.9m (POLX.L)
The medical imaging company announces its audited final results for the year ended 31 December 2022. FDA approval was received for the Company’s drug device combination product, XENOVIEW (xenon Xe 129 hyperpolarised). Simultaneously with the approval of the XENOVIEW NDA, two 510(k) devices were also cleared by the FDA. The Company holds Net cash of US$16.4m as of 31 December 2022.
Prospex Energy 8.5p £24.2m (PXEN.L)
The investment company focused on gas production and electricity on high impact, late stage onshore European opportunities, announced its audited final results for the year ended 31 December 2022. Total Assets of £16.06m up 240% from £6.69m in 2021, reflecting the after-tax effect of the revaluation of the Company's working interest in the Podere Gallina licence in Italy increasing to 37% from 17% which completed in April 2022. The combined value of these equity investments, current and non-current loans is £21.5m up from £8.7m in 2021, a 221% increase. The Company has also completed a placing of £2.4m in February and holds cash equivalents of £1.48m. Gross monthly revenue from electricity generation at the El Romeral power plant in Spain peaked at over EUR500k in March 2022. The Company expects to deliver organic growth in its two main assets in Spain and Italy.
Tekcapital 13.5p £24.1m (TEK.L)
The UK intellectual property investment group focused on creating valuable companies from investing in university technologies that can improve people's lives, announces its audited results for the year ended 31 December 2022. Net Assets US$57.8m decreased 15% YoY (2021: US$68.1m), hence portfolio valuation also decreased to US$54.9m (2021: US$62.5m). Total loss after tax: US$12.7m, resulting primarily from net unrealised fair value reduction of US$11.0m (2021: profit of US$26.4m).
Tern 3.5p £13.6m (TERN.L)
The investment company specialising in supporting high growth, early-stage, disruptive Internet of Things technology businesses, announces that its portfolio company, InVMA Limited, which trades as Konektio has agreed a £2.5m equity fundraise, to be completed in two tranches. The first tranche of £1.2m has completed and the second tranche of £1.3m is due for completion in Q4 2023. Tern has invested £100k in the Konektio First Tranche and thus Tern's shareholding in Konektio has reduced to 28% from 39.9% prior. Tern has committed to invest a minimum of £0.28m in the Konektio Second Tranche, with an option, at its sole discretion, to increase its investment amount up to £0.4m.
Disclaimer
This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.
The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).
Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.
Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
If you would like to unsubscribe, please email enquiries@hybridan.com with “unsubscribe me”.
This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.
The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).
Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.
Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
If you would like to unsubscribe, please email enquiries@chrish351.sg-host.com with “unsubscribe me”.
